A detailed history of Duncan Williams Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Duncan Williams Asset Management, LLC holds 4,260 shares of ABBV stock, worth $725,691. This represents 0.46% of its overall portfolio holdings.

Number of Shares
4,260
Previous 1,806 135.88%
Holding current value
$725,691
Previous $310 Million 171.54%
% of portfolio
0.46%
Previous 0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$163.84 - $199.33 $402,063 - $489,155
2,454 Added 135.88%
4,260 $841 Million
Q2 2024

Jul 11, 2024

BUY
$154.79 - $180.76 $3,250 - $3,795
21 Added 1.18%
1,806 $310 Million
Q1 2024

Apr 03, 2024

BUY
$159.82 - $182.1 $285,278 - $325,048
1,785 New
1,785 $325 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Duncan Williams Asset Management, LLC Portfolio

Follow Duncan Williams Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duncan Williams Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Duncan Williams Asset Management, LLC with notifications on news.